6EJ

(1R)-1-[(4-{[(6,7-dihydro[1,4]dioxino[2,3-c]pyridazin-3-yl)methyl]amino}piperidin-1-yl)methyl]-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one



Chemical Component Summary

Name(1R)-1-[(4-{[(6,7-dihydro[1,4]dioxino[2,3-c]pyridazin-3-yl)methyl]amino}piperidin-1-yl)methyl]-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one
Identifiersn/a
FormulaC24 H26 F N5 O3
Molecular Weight451.49
TypeNON-POLYMER
Isomeric SMILESc1cc(c2c3c1C=CC(=O)N3C[C@H]2CN4CCC(CC4)NCc5cc6c(nn5)OCCO6)F
InChIInChI=1S/C24H26FN5O3/c25-19-3-1-15-2-4-21(31)30-14-16(22(19)23(15)30)13-29-7-5-17(6-8-29)26-12-18-11-20-24(28-27-18)33-10-9-32-20/h1-4,11,16-17,26H,5-10,12-14H2/t16-/m1/s1
InChIKeySRICOHRDRMZREQ-MRXNPFEDSA-N

Chemical Details

Formal Charge0
Atom Count59
Chiral Atom Count1
Bond Count64
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB15345 
NameGSK-945237
Groupsinvestigational
DescriptionGSK-945237 is under investigation in clinical trial NCT01039610 (A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.).
SynonymsGSK-945237
CategoriesHeterocyclic Compounds, Fused-Ring
CAS number944406-54-6

Related Resource References

Resource NameReference
PubChem119057475
ChEMBLCHEMBL3793226